Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Scholar Rock Holding stock
Learn how to easily invest in Scholar Rock Holding stock.
Scholar Rock Holding Corp is a biotechnology business based in the US. Scholar Rock Holding shares (SRRK) are listed on the NASDAQ and all prices are listed in US Dollars. Scholar Rock Holding employs 145 staff and has a trailing 12-month revenue of around $42.7 million.
How to buy shares in Scholar Rock Holding
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – SRRK – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Scholar Rock Holding stock price (NASDAQ: SRRK)Use our graph to track the performance of SRRK stocks over time.
Scholar Rock Holding shares at a glance
|Latest market close||$7.09|
|52-week range||$4.33 - $36.43|
|50-day moving average||$8.50|
|200-day moving average||$11.71|
|Wall St. target price||$26.71|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-3.03|
Buy Scholar Rock Holding shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Scholar Rock Holding stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Scholar Rock Holding price performance over time
|1 week (2022-09-27)||4.57%|
|1 month (2022-09-02)||-21.31%|
|3 months (2022-07-05)||20.58%|
|6 months (2022-04-05)||-47.83%|
|1 year (2021-10-05)||-75.78%|
|2 years (2020-10-05)||-54.41%|
|3 years (2019-10-04)||9.36|
|5 years (2017-10-01)||N/A|
Scholar Rock Holding financials
|Revenue TTM||$42.7 million|
|Gross profit TTM||$18.8 million|
|Return on assets TTM||-20.25%|
|Return on equity TTM||-45.91%|
|Market capitalisation||$357.9 million|
TTM: trailing 12 months
Scholar Rock Holding share dividends
We're not expecting Scholar Rock Holding to pay a dividend over the next 12 months.
Scholar Rock Holding share price volatility
Over the last 12 months, Scholar Rock Holding's shares have ranged in value from as little as $4.325 up to $36.43. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Scholar Rock Holding's is 0.5455. This would suggest that Scholar Rock Holding's shares are less volatile than average (for this exchange).
Scholar Rock Holding overview
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clinical trials for the treatment of spinal muscular atrophy; and SRK-181, which is in Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is also developing a pipeline of novel product candidates with potential to transform the lives of patients suffering from a range of serious diseases, including neuromuscular disorders, cancer, and fibrosis. The company has a collaboration agreement with Gilead Sciences, Inc. to discover and develop specific inhibitors of transforming growth factor beta activation for the treatment of fibrotic diseases. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts. .
Scholar Rock Holding in the news
Scholar Rock to Present New 24-Month Data from Phase 2 TOPAZ Study at Two International Conferences: World Muscle Society Congress and International Scientific Congress on Spinal Muscular Atrophy
Scholar Rock Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Scholar Rock Appoints Jay Backstrom, M.D., M.P.H., to be its Next Chief Executive Officer
Frequently asked questionsWhat percentage of Scholar Rock Holding is owned by insiders or institutions?
Currently 2.857% of Scholar Rock Holding shares are held by insiders and 102.869% by institutions. How many people work for Scholar Rock Holding?
Latest data suggests 145 work at Scholar Rock Holding. When does the fiscal year end for Scholar Rock Holding?
Scholar Rock Holding's fiscal year ends in December. Where is Scholar Rock Holding based?
Scholar Rock Holding's address is: 301 Binney Street, Cambridge, MA, United States, 02142 What is Scholar Rock Holding's ISIN number?
Scholar Rock Holding's international securities identification number is: US80706P1030 What is Scholar Rock Holding's CUSIP number?
Scholar Rock Holding's Committee on Uniform Securities Identification Procedures number is: 80706P103
More guides on Finder
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
Ask an Expert